PROVIDER PROFILE · NPI 1760603989

Christine QuatelaNP

PRACTICESRIKRISHNA, INC.See all providers at this practice →

Nurse PractitionerRochester, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$5K

Peer benchmark

Total Medicare services vs. 10,295 Nurse Practitioner providers in NY — below median (cohort median 188).

PRESCRIBING · PART D · 2024

Total Rx claims

8,049

Beneficiaries

—

Total drug cost

$401K

Distinct drugs

112

Brand share

15.7%

Top prescribed drugs

Atorvastatin Calcium627 claims

Levothyroxine Sodium456 claims

Lisinopril426 claims

Amlodipine Besylate387 claims

Omeprazole288 claims

QUALITY · MIPS · 2024

Final MIPS score

96.6

Quality

74.5

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.91%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Christine Quatela's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
ROCHESTER GENERAL HOSPITAL	109	479
Jane Salamone Internal Medicine · Rochester, NY	44	198
Sudipt Deshmukh Internal Medicine · Rochester, NY	21	53
Kimberly Peterson Internal Medicine · Rochester, NY	17	42
RICHARDSON, LOUISE	14	60
ACM MEDICAL LABORATORY INC	11	22

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history